Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

Description

At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

Kamsa

Integrations

Kamsa

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Altis Labs

Founded

2019

Country

Canada

Website

www.altislabs.com/news/altis-labs-announces-launch-of-nota-a-clinical-information-platform-to-accelerate-therapeutic-r-d

Vendor Details

Company Name

PathAI

Founded

2016

Country

United States

Website

www.pathai.com

Product Features

Product Features

Alternatives

Alternatives

LaunchX Reviews

LaunchX

Nota AI
Ember Reviews

Ember

MetiStream
VistaPath Sentinel Reviews

VistaPath Sentinel

VistaPath Biosystems